BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 9245224)

  • 1. Outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.
    Hamel MB; Phillips RS; Davis RB; Desbiens N; Connors AF; Teno JM; Wenger N; Lynn J; Wu AW; Fulkerson W; Tsevat J
    Ann Intern Med; 1997 Aug; 127(3):195-202. PubMed ID: 9245224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes and cost-effectiveness of ventilator support and aggressive care for patients with acute respiratory failure due to pneumonia or acute respiratory distress syndrome.
    Hamel MB; Phillips RS; Davis RB; Teno J; Connors AF; Desbiens N; Lynn J; Dawson NV; Fulkerson W; Tsevat J
    Am J Med; 2000 Dec; 109(8):614-20. PubMed ID: 11099680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seriously ill hospitalized adults: do we spend less on older patients? Support Investigators. Study to Understand Prognoses and Preference for Outcomes and Risks of Treatments.
    Hamel MB; Phillips RS; Teno JM; Lynn J; Galanos AN; Davis RB; Connors AF; Oye RK; Desbiens N; Reding DJ; Goldman L
    J Am Geriatr Soc; 1996 Sep; 44(9):1043-8. PubMed ID: 8790228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are aggressive treatment strategies less cost-effective for older patients? The case of ventilator support and aggressive care for patients with acute respiratory failure.
    Hamel MB; Phillips RS; Davis RB; Teno J; Desbiens N; Lynn J; Tsevat J
    J Am Geriatr Soc; 2001 Apr; 49(4):382-90. PubMed ID: 11347780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness of aggressive care for patients with nontraumatic coma.
    Hamel MB; Phillips R; Teno J; Davis RB; Goldman L; Lynn J; Desbiens N; Connors AF; Tsevat J
    Crit Care Med; 2002 Jun; 30(6):1191-6. PubMed ID: 12072667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Older age, aggressiveness of care, and survival for seriously ill, hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.
    Hamel MB; Davis RB; Teno JM; Knaus WA; Lynn J; Harrell F; Galanos AN; Wu AW; Phillips RS
    Ann Intern Med; 1999 Nov; 131(10):721-8. PubMed ID: 10577294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient age and decisions to withhold life-sustaining treatments from seriously ill, hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment.
    Hamel MB; Teno JM; Goldman L; Lynn J; Davis RB; Galanos AN; Desbiens N; Connors AF; Wenger N; Phillips RS
    Ann Intern Med; 1999 Jan; 130(2):116-25. PubMed ID: 10068357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related differences in care preferences, treatment decisions, and clinical outcomes of seriously ill hospitalized adults: lessons from SUPPORT.
    Hamel MB; Lynn J; Teno JM; Covinsky KE; Wu AW; Galanos A; Desbiens NA; Phillips RS
    J Am Geriatr Soc; 2000 May; 48(S1):S176-82. PubMed ID: 10809472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators.
    JAMA; 1995 Nov 22-29; 274(20):1591-8. PubMed ID: 7474243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decision-making and outcomes of prolonged ICU stays in seriously ill patients.
    Teno JM; Fisher E; Hamel MB; Wu AW; Murphy DJ; Wenger NS; Lynn J; Harrell FE
    J Am Geriatr Soc; 2000 May; 48(S1):S70-4. PubMed ID: 10809459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis-based futility guidelines: does anyone win? SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment.
    Teno JM; Murphy D; Lynn J; Tosteson A; Desbiens N; Connors AF; Hamel MB; Wu A; Phillips R; Wenger N
    J Am Geriatr Soc; 1994 Nov; 42(11):1202-7. PubMed ID: 7963209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.
    Yang F; Lau T; Luo N
    Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of hemodialysis and peritoneal dialysis: A national cohort study with 14 years follow-up and matched for comorbidities and propensity score.
    Chang YT; Hwang JS; Hung SY; Tsai MS; Wu JL; Sung JM; Wang JD
    Sci Rep; 2016 Jul; 6():30266. PubMed ID: 27461186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The illusion of end-of-life resource savings with advance directives. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment.
    Teno J; Lynn J; Connors AF; Wenger N; Phillips RS; Alzola C; Murphy DP; Desbiens N; Knaus WA
    J Am Geriatr Soc; 1997 Apr; 45(4):513-8. PubMed ID: 9100723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of nutritional supplementation on survival in seriously ill hospitalized adults: an evaluation of the SUPPORT data. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.
    Borum ML; Lynn J; Zhong Z; Roth K; Connors AF; Desbiens NA; Phillips RS; Dawson NV
    J Am Geriatr Soc; 2000 May; 48(S1):S33-8. PubMed ID: 10809454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dying with end stage liver disease with cirrhosis: insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment.
    Roth K; Lynn J; Zhong Z; Borum M; Dawson NV
    J Am Geriatr Soc; 2000 May; 48(S1):S122-30. PubMed ID: 10809465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient race and decisions to withhold or withdraw life-sustaining treatments for seriously ill hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.
    Phillips RS; Hamel MB; Teno JM; Soukup J; Lynn J; Califf R; Vidaillet H; Davis RB; Bellamy P; Goldman L
    Am J Med; 2000 Jan; 108(1):14-9. PubMed ID: 11059436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.
    Claessens MT; Lynn J; Zhong Z; Desbiens NA; Phillips RS; Wu AW; Harrell FE; Connors AF
    J Am Geriatr Soc; 2000 May; 48(S1):S146-53. PubMed ID: 10809468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health values of the seriously ill. SUPPORT investigators.
    Tsevat J; Cook EF; Green ML; Matchar DB; Dawson NV; Broste SK; Wu AW; Phillips RS; Oye RK; Goldman L
    Ann Intern Med; 1995 Apr; 122(7):514-20. PubMed ID: 7872587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resource use and survival of patients hospitalized with congestive heart failure: differences in care by specialty of the attending physician. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.
    Auerbach AD; Hamel MB; Davis RB; Connors AF; Regueiro C; Desbiens N; Goldman L; Califf RM; Dawson NV; Wenger N; Vidaillet H; Phillips RS
    Ann Intern Med; 2000 Feb; 132(3):191-200. PubMed ID: 10651599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.